Aspire Private Capital’s BioCardia BCDA Stock Holding History

Aspire Private Capital’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20	Closed	-$585	–	676
2023 Q1	$585	Hold	20	–	–	﹤0.01%	595
2022 Q4	$627	Hold	20	–	–	﹤0.01%	584
2022 Q3	$1K	Hold	20	–	–	﹤0.01%	545
2022 Q2	$0	Buy	+20	New	+$479	﹤0.01%	606

Other funds holding BCDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Family Management New York $834M AUM 20.83% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

Aspire Private Capital's BCDA Position: Q2 2023 in Review

Aspire Private Capital sold out of BioCardia (BCDA) in Q2 2023, closing a stake of 20 shares — an estimated $585 sold.

Aspire Private Capital first reported a position in BCDA in Q2 2022 and held it in 4 quarters. The position peaked at $1K in Q3 2022. 23 funds tracked by Wall St. Rank hold BCDA as of Q2 2023.

Aspire Private Capital reported no remaining BioCardia position as of Q2 2023 after selling out during the quarter.
Aspire Private Capital sold 20 BioCardia shares in Q2 2023, an estimated $585.
Aspire Private Capital first reported a position in BioCardia in Q2 2022 and held it in 4 quarters.
Aspire Private Capital's BioCardia position peaked at $1K in Q3 2022.
23 funds tracked by Wall St. Rank held BioCardia as of Q2 2023.

Based on Aspire Private Capital's 13F filing for Q2 2023, filed 24 Jul 2023.